Skip to content
Search

Latest Stories

PSNC launches first consultation within pharmacy vision project

The Pharmaceutical Services Negotiating Committee (PSNC) has invited pharmacy contractors, LPCs and others in the sector to share their views on an open consultation on the “future of community pharmacy”.

“The consultation – which takes the form of an online survey – is the first opportunity within PSNC’s vision project for individuals and organisations to share their thoughts with Nuffield Trust and The King’s Fund,” said PSNC.


The survey is happening in addition to an extensive programme of research, interviews and initial meetings of the vision Steering Group, Advisory Panel, and Working Groups, all of which have contractors, LPCs and other representatives of the sector at their heart.

The online survey, asks five questions on topics such as Future policy goals; Why previous reviews and policies may not have fully achieved their objectives; Design principles that should underpin the service offer made by community pharmacy; and Blocks and enablers for change.

The deadline for responses is 11.59pm on Friday 9th December 2022.

PSNC will be hosting some online engagement events early in 2023. These will allow any contractors who would prefer not to submit a written consultation response to input into this stage of the vision work.

The responses to the survey, and a summary of the engagement events, will be shared with Nuffield Trust and The King’s Fund – in anonymised form – to help inform their thinking as they develop the new vision and strategic options for community pharmacy.

This work has been commissioned by PSNC to help underpin the future strategy for the sector and to lay the ground for the next Community Pharmacy Contractual Framework (CPCF) negotiations which will be critical for the future of all community pharmacies.

The open consultation is the first opportunity for the sector to input into the work – a further consultation will take place in spring 2023 to test the initial report from Nuffield Trust and The King’s Fund.

The initial consultation was launch yesterday (09 November) and will run until 11.59pm on Friday 9th December 2022.

Commenting on the launch of the consultation, Janet Morrison, PSNC Chief Executive, said: “As community pharmacies continue to face insurmountable financial and other pressures, the development of a new vision and strategic options is critical; this is a first step towards getting the sector onto a more sustainable path. By commissioning Nuffield Trust and The King’s Fund to do this work PSNC wants to increase the credibility of our shared vision, develop a more effective strategy, and have more chance of shaking up Government and NHS thinking about community pharmacy.

“But while Nuffield Trust and The King’s Fund bring unrivalled health policy expertise, they also need to hear from the experts in community pharmacy, and that means you. We have ensured this will happen by putting contractors, LPCs and other sector representatives at the heart of the project – including on the Steering Group, Advisory Panel and Working Groups – but we also want to hear from anyone with ideas, thoughts or a vision for the future.”

“This consultation is the first chance to do that and to hear from you about what would – and wouldn’t – work in community pharmacies of the future, and what needs to change to make it happen.

“We are really looking forward to hearing from you either through our online survey or at one of our engagement events. If you are a contractor, you may also have the option to feed in views via your LPC or trade association. The views we gather now will help the vision project team to understand why previous policies have been slow to progress and how to build a new vision that will stick. This vision will be critical to the future, and we look forward to working with you on it.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less